Come up with a name for your new list and we'll add to it:
Epigenomics raised a round of funding on April 28, 2017. Investors include
Cathay Fortune International.
Epigenomics is a molecular diagnostics company focusing on blood-based detection of cancers using its proprietary DNA methylation technology. The company develops and commercializes blood-based diagno…